Exos TFP Holdings’s ResMed RMD Stock Holding History

Exos TFP Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,443	Closed	-$754K	–	375
2023 Q1	$754K	Buy	3,443 +1,769	+106%	+$384K	0.19%	149
2022 Q4	$348K	Buy	1,674 +59	+4%	+$13K	0.1%	190
2022 Q3	$353K	Buy	+1,615	New	+$368K	0.16%	157

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exos TFP Holdings's RMD Position: Q2 2023 in Review

Exos TFP Holdings sold out of ResMed (RMD) in Q2 2023, closing a stake of 3,443 shares — an estimated $754K sold.

Exos TFP Holdings first reported a position in RMD in Q3 2022 and held it in 3 quarters. The position peaked at $754K in Q1 2023. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Exos TFP Holdings reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
Exos TFP Holdings sold 3,443 ResMed shares in Q2 2023, an estimated $754K.
Exos TFP Holdings first reported a position in ResMed in Q3 2022 and held it in 3 quarters.
Exos TFP Holdings's ResMed position peaked at $754K in Q1 2023.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.